GAMMA Investing LLC Raises Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

GAMMA Investing LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 9.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,115 shares of the medical equipment provider's stock after acquiring an additional 518 shares during the period. GAMMA Investing LLC's holdings in Intuitive Surgical were worth $3,029,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Atala Financial Inc bought a new position in shares of Intuitive Surgical during the fourth quarter valued at $25,000. Hurley Capital LLC bought a new position in shares of Intuitive Surgical during the fourth quarter valued at $28,000. Parvin Asset Management LLC bought a new position in shares of Intuitive Surgical during the fourth quarter valued at $26,000. Global Financial Private Client LLC increased its holdings in shares of Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after acquiring an additional 38 shares in the last quarter. Finally, Summit Securities Group LLC bought a new position in shares of Intuitive Surgical during the fourth quarter valued at $30,000. 83.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms recently commented on ISRG. Truist Financial dropped their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd. Robert W. Baird reduced their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Citigroup reiterated a "buy" rating and issued a $650.00 price objective (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Barclays reduced their price objective on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. Finally, Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a "hold" rating to a "sell" rating and reduced their price objective for the stock from $515.00 to $440.00 in a report on Monday, June 9th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $588.95.

Intuitive Surgical Stock Down 0.1%

Shares of Intuitive Surgical stock traded down $0.48 during trading hours on Friday, reaching $533.71. 2,014,026 shares of the stock traded hands, compared to its average volume of 1,669,756. The company has a 50 day moving average price of $532.08 and a 200 day moving average price of $536.75. The firm has a market capitalization of $191.29 billion, a price-to-earnings ratio of 78.26, a P/E/G ratio of 5.66 and a beta of 1.67. Intuitive Surgical, Inc. has a one year low of $413.82 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same period in the previous year, the company posted $1.50 EPS. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of the business's stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,695,113.84. The trade was a 3.47% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of the business's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the transaction, the director now owns 6,371 shares of the company's stock, valued at approximately $3,312,920. This trade represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 4,998 shares of company stock worth $2,611,577. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.